Preclinical in vivo rodent studies have demonstrated that hyperinsulinemia can activate not only its cognate IR but can also bind to and hence stimulate the insulin-like growth factor 1 receptor (IGF1R). This evidence concerns the gene IGF1R and Hyperinsulinemia.